CRDF:Cardiff Oncology Inc Snapshot | Charting | News | Options
$4.35 NASDAQ 4:05p ET
April 8 '24 		Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-l... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
     GlobeNewswire
    Full Story →

    Headline News
    Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics?
    9:31a ET March 26 '24 PR Newswire
    Thinking about buying stock in Mind Medicine, Ocean Biomedical, Archer Aviation, Outlook Therapeutics, or Cardiff Oncology?
    9:45a ET March 15 '24 PR Newswire
    Thinking about buying stock in SoundHound AI, Kinross Gold, Nu Holdings, Cardiff Oncology, or Turtle Beach?
    9:31a ET March 14 '24 PR Newswire
    More News →
    Day  0.46%Week  22.46%Month  12.30%More Charting →
    April 19 '24. Markets Closed.
    Last $4.35
    Day change   0.46%$0.02
    Open $4.38
    Gap at open $0.01
    Previous close $4.37
    Trading volume 606,899
    10 Day avg vol. 930,887
    Shares out. 44.7Mil
    Market cap. $194.3Mil
    Trading activity Below Avg.
    Previous data from yesterday, April 18 '24.

    Historical Price Performance
    3 month   188% 
    6 month   299% 
    1 year   218% 
    2 year   172% 

    Earnings
    Previous 12m -$0.93
    Next 12m Estimate -$0.98
    P/E ratio 4.7x
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.